BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 15986337)

  • 21. More about the link between thrombosis and atherosclerosis in autoimmune diseases: triglycerides and risk for thrombosis in patients with antiphospholipid antibodies.
    Garrido JA; Peromingo JA; Sesma P; Pia G
    J Rheumatol; 1994 Dec; 21(12):2394. PubMed ID: 7699654
    [No Abstract]   [Full Text] [Related]  

  • 22. Cerebral and corpus callosum atrophy in systemic lupus erythematosus.
    Appenzeller S; Rondina JM; Li LM; Costallat LT; Cendes F
    Arthritis Rheum; 2005 Sep; 52(9):2783-9. PubMed ID: 16142703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary anetoderma associated with antiphospholipid antibodies and micromorphologic vascular lesions: case report and literature review.
    Rados J; Dobrić I; Ledić Drvar D; Loncarić D
    Acta Dermatovenerol Croat; 2005; 13(3):177-83. PubMed ID: 16146621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ulceration of striae distensae in a patient with systemic lupus erythematosus.
    Cordeiro RC; Moraes AM
    J Eur Acad Dermatol Venereol; 2008 Mar; 22(3):390-2. PubMed ID: 18269620
    [No Abstract]   [Full Text] [Related]  

  • 25. Elastic fibre abnormalities in skin disorders: what's new?
    Uitto J
    J Eur Acad Dermatol Venereol; 2001 Jul; 15(4):303-4. PubMed ID: 11730038
    [No Abstract]   [Full Text] [Related]  

  • 26. Anetoderma: an alert for antiphospholipid antibody syndrome.
    Genta MP; Abreu MAMM; Nai GA
    An Bras Dermatol; 2020; 95(1):123-125. PubMed ID: 31987491
    [No Abstract]   [Full Text] [Related]  

  • 27. Anetoderma secondary to antiphospholipid antibodies.
    Eungdamrong J; Fischer M; Patel R; Meehan S; Sanchez M
    Dermatol Online J; 2012 Dec; 18(12):26. PubMed ID: 23286816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How to manage patients with systemic lupus erythematosus who are also antiphospholipid antibody positive.
    Giles I; Rahman A
    Best Pract Res Clin Rheumatol; 2009 Aug; 23(4):525-37. PubMed ID: 19591782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Panniculitis in connective tissue disease.
    Winkelmann RK
    Arch Dermatol; 1983 Apr; 119(4):336-44. PubMed ID: 6340615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pulmonary thromboembolism as the first manifestation of systemic lupus erythematosus].
    Corres González J; Quereda Rodríguez-Navarro C; Orte Martínez J; Pérez Rodríguez E
    An Med Interna; 1989 Nov; 6(11):606-7. PubMed ID: 2562710
    [No Abstract]   [Full Text] [Related]  

  • 31. Neonatal lupus in triplet pregnancy of a patient with undifferentiated connective tissue disease evolving to systemic lupus erythematosus.
    Demaestri M; Sciascia S; Kuzenko A; Bergia R; Barberis L; Lanza MG; Bertero MT
    Lupus; 2009 Apr; 18(4):368-71. PubMed ID: 19276307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Changes in the aorta and major arteries in systemic lupus erythematosus].
    Kakturskiĭ LV
    Arkh Patol; 1971; 33(7):56-61. PubMed ID: 4258167
    [No Abstract]   [Full Text] [Related]  

  • 33. Ultrastructure of dermal lesions in systemic lupus erythematosus.
    Grishman E; Churg J
    Lab Invest; 1970 Mar; 22(3):189-97. PubMed ID: 5436514
    [No Abstract]   [Full Text] [Related]  

  • 34. Generalized laxity of connective tissue as a possible syndrome in systemic lupus erythematosus.
    Nakamura K; Tajima Y; Takai O
    Mod Rheumatol; 2010 Oct; 20(5):522-7. PubMed ID: 20549288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiphospholipid antibodies and valve disease in patients with systemic lupus erythematosus.
    Khamashta MA; Hughes GR
    J Am Coll Cardiol; 1993 Oct; 22(4):1269-70. PubMed ID: 8409067
    [No Abstract]   [Full Text] [Related]  

  • 36. Primary anetoderma and antiphospholipid antibodies--review of the literature.
    Hodak E; David M
    Clin Rev Allergy Immunol; 2007 Apr; 32(2):162-6. PubMed ID: 17916987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Unusual variant of pulmonary lesion (lymphocytic interstitial pneumonitis) in systemic lupus erythematosus].
    Blagova OV; Sarkisova ND; Nedostup AV; Petukhova NV; Rodionov AV
    Ter Arkh; 2008; 80(5):79-82. PubMed ID: 18590122
    [No Abstract]   [Full Text] [Related]  

  • 38. Longitudinally extensive myelitis in a patient with characteristic autoantibody profile of systemic lupus erythematosus: a challenging etiological diagnosis.
    Falgàs N; Sola-Valls N; Sepúlveda M; Lapuma D; Ariño H; Llufriu S; Espinosa G; Saiz A
    Lupus; 2014 Dec; 23(14):1555-6. PubMed ID: 25107937
    [No Abstract]   [Full Text] [Related]  

  • 39. Antibodies to beta2-glycoprotein-I: relation of anticardiolipin antibodies with clinical and laboratory parameters in patients with systemic lupus erythematosus.
    Sahin M; Duzgun N; Tunc SE; Tutkak H
    Clin Biochem; 2007 May; 40(8):526-30. PubMed ID: 17359958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sole existence of antithrombin antibody in patients with systemic lupus erythematosus showing tendency of its antigenic determinants directing against exosite II (antithrombin/heparin binding site) of thrombin.
    Matsuda J; Matsuyama A; Atsumi G; Ohkura N
    Blood Coagul Fibrinolysis; 2008 Jan; 19(1):66-9. PubMed ID: 18180618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.